4.8 Article

The Metabolic Chemical Reporter 6-Azido-6-deoxy-glucose Further Reveals the Substrate Promiscuity of O-GlcNAc Transferase and Catalyzes the Discovery of Intracellular Protein Modification by O-Glucose

Journal

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 140, Issue 23, Pages 7092-7100

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jacs.7b13488

Keywords

-

Funding

  1. National Science Foundation [CHE-1506503]
  2. Damon Runyon Cancer Research Foundation [DDR-19-12]
  3. Susan G. Komen for the Cure [CCR14299333]
  4. American Cancer Society [RSG-14-225-01-CCG]
  5. National Institutes of Health [R01GM125939]
  6. Burroughs Wellcome Fund CASI
  7. Harvard University
  8. National Cancer Institute of the US National Institutes of Health [CCSG P30CA014089]
  9. NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER
  10. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125939] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Metabolic chemical reporters of glycosylation in combination with bioorthogonal reactions have been known for two decades and have been used by many different research laboratories for the identification and visualization of glycoconjugates. More recently, however, they have begun to see utility for the investigation of cellular metabolism and the tolerance of biosynthetic enzymes and glycosyltransferases to different sugars. Here, we take this concept one step further by using the metabolic chemical reporter 6-azido-6-deoxy-glucose (6AzGlc). We show that treatment of mammalian cells with the per-O-acetylated version of 6AzGlc results in robust labeling of a variety of proteins. Notably, the pattern of this labeling was consistent with O-GlcNAc modifications, suggesting that the enzyme O-GlcNAc transferase is quite promiscuous for its donor sugar substrates. To confirm this possibility, we show that 6AzGlc-treatment results in the labeling of known O-GlcNAcylated proteins, that the UDP-6AzGlc donor sugar is indeed produced in living cells, and that recombinant OGT will accept UDP-6AzGlc as a substrate in vitro. Finally, we use proteomics to first identify several bona fide 6AzGlc-modifications in mammalian cells and then an endogenous O-glucose modification on host cell factor. These results support the conclusion that OGT can endogenously modify proteins with both N-acetyl-glucosamine and glucose, raising the possibility that intracellular O-glucose modification may be a widespread modification under certain conditions or in particular tissues.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available